Compounding pharmacies aren’t the only makers of off-brand versions of Novo Nordisk’s Wegovy and Eli Lilly’s Zepbound. The ...

Court rulings against parts of Donald Trump's agenda put White House officials on the defensive. Hamas says it will not ...

The next FDA Commissioner could solve two big problems with one powerful policy: encourage independent testing of both ...

PATIENTS taking blockbuster diabetes and weight loss drugs are waking up with vision loss, researchers warn. Some reported ...

Recent research suggests that a new approach could help even patients with advanced forms of fatty liver disease.

Experts warn Ozempic and Mounjaro may cause sudden, irreversible blindness as patients report vision loss after taking the weight loss drugs.

The telehealth company Hims & Hers put out a Super Bowl ad that skimped on clarifying that its compounded semaglutide ...

The popular weight-loss drugs known as GLP-1 receptor agonists, which were originally meant to treat diabetes, surged in ...

Ozempic and Wegovy maker Novo Nordisk placed a print ad responding to the Super Bowl spot from competitor Hims & Hers.

A well-known class of drugs used to manage type 2 diabetes and control weight could offer hope for patients who also struggle ...

The Hims brand has primed people to view both their everyday health and the natural-aging processes as problems that can be ...

As Ozempic use rises, some patients report unexpected nasal symptoms, prompting researchers to investigate this new and unusual side effect.